Caricamento...
Optimizing the use of biological therapy in patients with inflammatory bowel disease
Biological therapy revolutionized the treatment of inflammatory bowel disease (IBD) during the last decade. These monoclonal antibodies, which target tumor necrosis factor (TNF), integrins or IL12/23, have been approved—or are in development for—both Crohn’s disease (CD) and ulcerative colitis (UC)....
Salvato in:
| Pubblicato in: | Gastroenterol Rep (Oxf) |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4324872/ https://ncbi.nlm.nih.gov/pubmed/25567472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gastro/gou087 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|